The core business here is cash-market exchange, clearing, listing fees, market-data economics, and especially derivatives growth The management question I keep coming back to is market-share retention, product innovation, and technology reliability under volume spikes. Are people on this room still underwriting strong execution, or has the risk-reward changed enough that governance, pacing, or client concentration should be treated more seriously now?
I am still positive because the business model is not generic. cash-market exchange, clearing, listing fees, market-data economics, and especially derivatives growth If management keeps executing there, the quality premium can stay justified.
Management quality matters, but I would not ignore the failure mode. the multiple can compress sharply if regulation or market-share assumptions shift even modestly. Once the market stops giving the benefit of doubt, recovery takes longer than people expect.